Search

everythinglearnresearchcommunity

for

Search:↓

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

New therapies are being developed that target integrin pathways to treat various diseases.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Frontal fibrosing alopecia may affect nails and could be a type of lichen planus, treatable with certain medications.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

A woman's progressive hair loss was correctly diagnosed as a rare condition called fibrosing alopecia in a pattern distribution after initially being mistaken for a more common type.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Stress may trigger hair loss by affecting immune protection in hair follicles.

2-deoxy D-glucose does not help with hair regrowth in alopecia areata.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

Understanding how cells die in the skin is important for treating skin diseases and preventing hair loss.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Simvastatin helps hair regrowth in autoimmune alopecia by directly affecting T cells.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

NK cells play a role in skin diseases like eczema and psoriasis.

Blood pressure drugs can cause skin lupus, but it improves after stopping the drug. The glycoprotein D vaccine works against genital herpes in some women, and the HPV-16 vaccine reduces HPV-16 infection and related diseases. More frequent light therapy clears psoriasis faster. A cream called imiquimod effectively treats a type of skin cancer. Iron supplements don't necessarily help with chronic hair loss in women.

Interferon gamma alone can't cause alopecia areata in C3H/HeJ mice.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.